G2P Blog

A Tribute to Franca Sozzani: Celebrating FiveYears of the Franca Sozzani Fund for Preventive Genomics

Medium |
March 2024
G2P Blog

Pakhi Dixit, who manages social media for Genomes2People, writes a tribute to Franca Sozzani in the latest G2P blog. She highlights Franca’s powerful legacy and story behind the Franca Sozzani Fund for Preventive Genomics which was created to, “leverage evidence and advocacy around preventive genomics so that everyone, regardless of ethnicity or socioeconomic background, may … Continued

How Genomics Could Save Your Life

Medium |
February 2024
G2P Blog

In this blog post, Dr. Robert Green poses the question: “What’s holding us back from doing more with preventive genomics in medicine?” Drawing on his recent keynote talk at the Precision Medicine Network (PMNET) Forum in Riga, Latvia, Dr. Green explores near-term applications of precision medicine using genetic testing such as: newborn and childhood sequencing, … Continued

Global leaders convene in London: Advancing newborn sequencing on an international scale

Medium |
October 2023
G2P Blog

Earlier this month, leading researchers and experts in genomics and newborn sequencing representing the U.S., the U.K., Europe, Australia, and the Middle East came together in London at the Royal Institution for the second annual International Conference on Newborn Sequencing co-hosted with Genomics England to present updates regarding their own research and share future plans.

Precision screening for health equity

Medium |
June 2023
G2P Blog

“Addressing stark, deeply-rooted racial disparities in healthcare has to be a priority for medical research. PRS might be one tool to improve disease screening and move us beyond race-based medical decision-making and toward more equitable health outcomes.”

From researcher to patient: Knowledge is power

Medium |
October 2022
G2P Blog

Last year, our former research assistant, Charlene Preys, underwent genetic counseling and testing for hereditary cancer associated with the ATM gene. Upon receiving her ATM status, Charlene’s risk of developing breast cancer jumped from 12 to 40%, and her risk of developing pancreatic cancer increased from <1% to 10%. Patient organizations and support groups were … Continued

Unlocking the human genetics of COVID

Medium |
July 2021
G2P Blog

In an unprecedented international effort, researchers and clinicians tackle the genomics of COVID-19 risk. In this blog post, G2P Director Robert Green writes about what we’ve learned so far concerning genetics and COVID-19 and how the G2P research program has contributed to these growing studies.

Precision medicine: From breakthrough to follow-through

Medium |
May 2021
G2P Blog

Nic Encina, Director of Strategy of the Precision Population Health (PPH) Initiative at Ariadne Labs, describes the recent launch of PPH into the world of precision medicine. “We feel that Genomes2People’s real-world research in genomic return-of-results combined with Ariadne Labs’ practical approach to health system innovation and implementation are aptly suited for tackling implementation obstacles … Continued

Genomic literacy in high school: Building the future

Medium |
April 2021
G2P Blog

In this blog post, G2P trainee Sachi Badola speaks to the importance of genetic literacy and proposes a genetics elective to be offered to all high school students that comprehensively covers the implications, limitations, and challenges of genomic medicine and precision health.

A pharmacist’s journey into genomic medicine

Medium |
February 2021
G2P Blog

Former G2P trainee Cathelijne van der Wouden, PharmD, shares about her journey into genomic medicine as a pharmacist-in-training in this G2P blog post.

Genetic counselors and the fight for medicare recognition

Medium |
May 2020
G2P Blog

Elizabeth Fieg, MS, LCGC discusses the importance and implication of the H.R. 3235-The Access to Genetic Counselor Service Act that would authorize and recognize appropriately credentialed genetic counselors as reimbursable providers under Medicare.

Econogenomics: The economics of genomic testing for health

Medium |
January 2020
G2P Blog

“The cost of sequencing itself is already comparable to a lot of other diagnostic tests regularly used in medicine,” Kurt Christensen, PhD said. Besides: “What really moves the needle on cost effectiveness isn’t the costs — it’s the benefits.”

Is preventive genomics elitist?

Medium |
October 2019
G2P Blog

The ultimate aim of our Genomes2People Research Program is to contribute to the transformation of medicine from reactive to proactive, from treatment-oriented to preventive. We are trying to help build the evidence base that will justify societal decision to make these technologies and services accessible to anyone who wants them, regardless of means, education or … Continued

Is it too soon to consider genome sequencing for newborns?

Medium |
March 2019
G2P Blog

Parents and clinicians have their own ideas about newborn genome sequencing. Dr. Robert Green, principal investigator of the BabySeq Project, shares a detailed analysis of the results from the study and his thoughts on the utility of genomic sequencing for newborns in clinical care.

Studying personal genomics: Expanding the pool

Medium |
November 2018
G2P Blog

While a good deal of research has focused on finding information within the human genome that can diagnose rare conditions, far less work has been done to understand the longer-term consequences of identifying genetic risks in apparently healthy people. Read more the PeopleSeq Consoritum from the principal investigator, Dr. Robert Green!

Decoding FDA DTC policy

SOUNDROCKET |
November 2018
G2P Blog

Scott D. Crawford, Shawn Fayer, and Robert C. Green directly address and highlight some of the recent FDA movement in the direct-to-consumer (DTC) genetic testing space with a five-post blog compilation.

The true cost of whole genome sequencing

Medium |
September 2018
G2P Blog

The true costs of genome sequencing don’t end with the technical production of A’s, T’s, C’s and G’s, and they don’t even end with the molecular interpretation of a few dozen or even a few hundred genes.

Genomic sequencing for newborns: Are parents receptive?

Boston Children's Hospital |
September 2018
G2P Blog

Casie Genetti, MS, CGC, a licensed genetic counselor with the Manton Center for Orphan Disease Research at Boston Children’s Hospital is first author of a recently published paper on the BabySeq Project and author of this blog about parents’ receptiveness to genome sequencing.

Genome sequencing for healthy people: Will it be harmful?

Medium |
March 2018
G2P Blog

The second piece of a 2-part blog series authored by Dr. Robert C. Green. An early study found no problems related to unnecessary or harmful medical follow-ups after healthy people received their genome sequencing results. To read the first piece, visit: https://medium.com/@genomes2people/genome-sequencing-for-healthy-people-will-it-be-helpful-b984b94e3d3f

Genome sequencing for healthy people: Will it be helpful?

Medium |
February 2018
G2P Blog

The first piece of a 2-part blog series authored by Dr. Robert C. Green. Early results suggest that yes, whole genome sequencing may very well be substantially helpful to a significant number of healthy patients. To read the second piece, visit: https://medium.com/@genomes2people/genome-sequencing-for-healthy-people-will-it-be-harmful-d915cc08e634

You didn’t ask for these genomic test results, but they might save your life

Huffington Post |
April 2017
G2P Blog

We found that almost exactly 1% of the populations in both FHS and JHS carried a pathogenic variant in one of the original ACMG56 genes. And we found that those carrying pathogenic variants had an increased aggregated risk of developing clinical features associated with the corresponding diseases.

Genome for healthy people: Early results

Huffington Post |
January 2017
G2P Blog

This is part of our overall scientific mission to determine how personal genomic sequencing may impact participants’ long-term health, behavioral and economic outcomes.

Genome sequencing for healthy people: Is it time?

The Huffington Post |
September 2016
G2P Blog

A blog post authored by Dr. Robert Green discussing the benefits and challenges that people and health professionals are faced with when dealing with genetic testing and screening. Here, he addresses ethical issues and potential complications alongside beneficial factors that deal genome testing.

Should researchers share genomic results with participants’ relatives?

Huffington Post |
May 2016
G2P Blog

“When researchers discover something about a participant that could significantly affect that person’s relatives, do the researchers have a duty to tell the relatives? Are the researchers bound to protect the participant’s privacy even if the participant is deceased?”

Motivations for personalized genetic testing include explaining – not just predicting

Huffington Post |
January 2016
G2P Blog

A blog post written by Robert Green addresses why people are motivated for continued with personalized genetic testing. “Our study suggested that the motivations for this interest go beyond simply predicting risk… and that for these participants, their fascination with genetics was an attempt to understand the condition that they had,” he says.

Genomic sequencing: Just another tool in the doctor’s bag

Huffington Post |
December 2015
G2P Blog

Dr. Robert Green digs deeper into his one of his own projects, MedSeq. He explains the motivation behind the project, his hopes for what will be achieved, and how this study will lead to helping other doctors understand how genomics will help their patients individually.

Latest News From Genomes2People

April 2024
Press
MassMutual is rolling out free genetic testing for members, a dicey area for life insurers
More...
March 2024
Press
Interview: Nina Gold
More...
March 2024
G2P News
G2P March Newsletter 2024
More...